Celldex Therapeutics (CLDX) Stock Insights

CLDX price $29.66 -0.49 -1.63%

Ticker
CLDX
Price
$29.66
Change
-0.49 -1.63%
Market cap ?
$2.33B
P/E ?
-6.77
Forward P/E ?
7.80
Dividend yield ?
0.00%
Beta ?
0.90
Sector
Healthcare
Industry
Biotechnology

Financials

2016201720182019202020212022202320242025
67860001274300095380003573000741800046510002357000688300070200001500000

Celldex Therapeutics, Inc. is a biopharmaceutical company dedicated to developing antibody-based treatments, specifically monoclonal and bispecific antibodies, for a range of diseases. Their pipeline features therapeutic candidates aimed at both inflammatory conditions and various forms of cancer. Among their key clinical programs: CDX-0159 is a Phase I monoclonal antibody designed to bind to and inhibit the…

Fair value

CLDX fair value $74.70. Price $29.66. Price is 60% below fair value.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 397.96K. Growth 7.66%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 9.23% (beta 0.9). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 78.53M. Net debt -26.54M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare CLDX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-1.02—722.64K
2026-08-06-0.94-1.0622.00K734.92K
2026-05-07-1.18-1.1515.00K795.36K
2026-02-25-1.22-1.00100.00K1.32M
2025-11-10-1.01-0.88—985.82K
2025-08-07-0.85-0.86730.00K1.03M
2025-05-08-0.81-0.75695.00K997.60K
2025-02-27-0.71-0.731.18M1.02M
2024-11-06-0.64-0.693.19M835.56K
2024-08-08-0.54-0.592.50M854.29K
2024-05-06-0.56-0.67200.00K809.00K
2024-02-26-0.83-0.764.13M1.44M
2023-11-02-0.81-0.671.52M583.33K
2023-08-08-0.65-0.65268.00K528.00K
2023-05-04-0.62-0.63967.00K410.00K
2023-02-28-0.56-0.591.61M264.00K
2022-11-09-0.57-0.57407.00K360.00K
2022-08-08-0.77-0.46163.00K400.00K
2022-05-05-0.49-0.46174.00K560.00K
2022-02-28-0.43-0.42333.00K1.04M
2021-11-09-0.39-0.35153.00K640.00K
2021-08-05-0.34-0.403.48M685.00K
2021-05-06-0.42-0.32685.00K600.00K
2021-03-29-0.26-0.373.79M600.00K
2020-11-05-0.36-0.34668.00K668.00K
2020-08-06-0.50-0.58236.00K273.76K
2020-05-06-0.73-0.702.73M2.65M
2020-03-26-0.64-0.90887.00K1.25M
2019-11-12-0.75-0.84546.00K611.52K
2019-08-07-0.84-1.17715.00K995.89K
2019-05-07-1.40-1.141.43M1.16M
2019-03-07-0.81-1.201.76M2.61M
2018-11-07-1.20-2.25941.00K3.53M
2018-08-08-1.65-2.102.76M3.51M
2018-05-10-12.60-2.554.07M978.74K
2018-03-07-0.45-3.453.46M28.53M
2017-11-07-3.00-3.603.92M5.19M
2017-08-08-3.45-3.753.83M4.54M
2017-05-09-4.20-4.201.53M1.56M
2017-03-14-4.50-5.101.87M2.09M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-06-25Lawver Teri LBuy90.00K$34.093.07M
2026-06-25Jimenez Freddy A.Buy93.00K$34.093.17M
2026-06-25Young Diane C.Buy57.00K$34.091.94M
2026-06-25Heath-Chiozzi MargoBuy95.00K$34.093.24M
2026-06-25Martin Samuel BatesBuy93.00K$34.093.17M
2026-06-25Cavanaugh SarahBuy95.00K$34.093.24M
2026-06-25Crowley ElizabethBuy100.00K$34.093.41M
2026-06-25PEPIN RONALDBuy20.00K$34.09681.80K
2026-06-25KELER TIBORBuy115.00K$34.093.92M
2026-06-25Marucci Anthony SBuy375.00K$34.0912.78M
2026-06-25Torres DeniceBuy26.00K$34.09886.34K
2026-06-25Jain RitaBuy26.00K$34.09886.34K
2026-06-25NEIL GARRY ARTHURBuy26.00K$34.09886.34K
2026-06-25Cohen CherylBuy26.00K$34.09886.34K
2026-06-25Brownlie Keith LBuy26.00K$34.09886.34K
2026-06-25MARINO JAMES JBuy26.00K$34.09886.34K
2026-06-25CONRAD HERBERT JBuy26.00K$34.09886.34K
2026-06-25PENNER HARRY JRBuy26.00K$34.09886.34K
2026-01-02Martin Samuel BatesSell4.82K$10.3850.00K
2026-01-02Martin Samuel BatesBuy4.82K$10.3850.00K
2025-12-15PEPIN RONALDBuy11.00K$2.7830.58K
2025-12-15PEPIN RONALDBuy8.33K$9.0275.13K
2025-12-15PEPIN RONALDSell8.33K$9.0275.13K
2025-12-15PEPIN RONALDSell11.00K$2.7830.58K
2025-12-04Jimenez Freddy A.Sell4.17K$29.09121.21K
2025-11-13Wright Richard M.Buy15.75K$22.48354.06K
2025-11-13Wright Richard M.Buy26.67K$10.38276.86K
2025-11-13Wright Richard M.Buy6.88K$9.0262.00K
2025-11-13Wright Richard M.Sell49.30K$24.001.18M
2025-11-13Wright Richard M.Sell15.75K$22.48354.06K
2025-11-13Wright Richard M.Sell26.67K$10.38276.86K
2025-11-13Wright Richard M.Sell6.88K$9.0262.00K
2025-11-10Lawver Teri LBuy100.00K$22.672.27M
2025-11-10Lawver Teri LOther0——
2025-08-13Jimenez Freddy A.Sell341$23.958.17K
2025-08-13Jimenez Freddy A.Sell430$25.4110.93K
2025-06-05Cavanaugh SarahBuy78.00K$19.531.52M
2025-06-05Crowley ElizabethBuy85.00K$19.531.66M
2025-06-05Heath-Chiozzi MargoBuy82.00K$19.531.60M
2025-06-05Jimenez Freddy A.Buy75.00K$19.531.46M
2025-06-05Martin Samuel BatesBuy81.00K$19.531.58M
2025-06-05PEPIN RONALDBuy20.00K$19.53390.60K
2025-06-05Young Diane C.Buy72.00K$19.531.41M
2025-06-05KELER TIBORBuy93.00K$19.531.82M
2025-06-05Marucci Anthony SBuy300.00K$19.535.86M
2025-06-05Torres DeniceBuy33.00K$19.53644.49K
2025-06-05Jain RitaBuy16.50K$19.53322.25K
2025-06-05NEIL GARRY ARTHURBuy16.50K$19.53322.25K
2025-06-05PENNER HARRY JRBuy16.50K$19.53322.25K
2025-06-05CONRAD HERBERT JBuy16.50K$19.53322.25K
2025-06-05MARINO JAMES JBuy16.50K$19.53322.25K
2025-06-05Brownlie Keith LBuy16.50K$19.53322.25K
2025-06-05Cohen CherylBuy16.50K$19.53322.25K
2025-06-05Torres DeniceOther0——
2024-11-18MARINO JAMES JSell10.50K——
2024-11-11Marucci Anthony SBuy11.50K$26.82308.43K
2024-06-14Martin Samuel BatesSell16.97K$10.38176.13K
2024-06-14Martin Samuel BatesBuy16.97K$10.38176.13K
2024-06-14Martin Samuel BatesBuy3.20K$9.0228.86K
2024-06-14Martin Samuel BatesSell17.17K$35.42608.31K
2024-06-14Martin Samuel BatesSell3.20K$9.0228.86K
2024-06-14Crowley ElizabethSell30.00K$10.38311.40K
2024-06-14Crowley ElizabethBuy30.00K$10.38311.40K
2024-06-14Crowley ElizabethSell30.00K$34.871.05M
2024-06-13Jimenez Freddy A.Buy75.00K$36.432.73M
2024-06-13Young Diane C.Buy72.00K$36.432.62M
2024-06-13Heath-Chiozzi MargoBuy82.00K$36.432.99M
2024-06-13Cavanaugh SarahBuy78.00K$36.432.84M
2024-06-13Crowley ElizabethBuy85.00K$36.433.10M
2024-06-13Wright Richard M.Buy65.00K$36.432.37M
2024-06-13PEPIN RONALDBuy20.00K$36.43728.60K
2024-06-13Martin Samuel BatesBuy81.00K$36.432.95M
2024-06-13KELER TIBORBuy93.00K$36.433.39M
2024-06-13Marucci Anthony SBuy300.00K$36.4310.93M
2024-06-13Jain RitaBuy16.50K$36.43601.10K
2024-06-13NEIL GARRY ARTHURBuy16.50K$36.43601.10K
2024-06-13Cohen CherylBuy16.50K$36.43601.10K
2024-06-13Brownlie Keith LBuy16.50K$36.43601.10K
2024-06-13MARINO JAMES JBuy16.50K$36.43601.10K
2024-06-13CONRAD HERBERT JBuy16.50K$36.43601.10K
2024-06-13Shoos Karen L.Buy16.50K$36.43601.10K
2024-06-13PENNER HARRY JRBuy16.50K$36.43601.10K
2024-06-11Young Diane C.Buy15.00K$2.7140.65K
2024-06-11Young Diane C.Sell15.00K$2.7140.65K
2024-06-07Crowley ElizabethSell7.50K$10.3877.85K
2024-06-07Crowley ElizabethBuy7.50K$9.0267.62K
2024-06-07Crowley ElizabethBuy7.50K$10.3877.85K
2024-06-07Crowley ElizabethSell15.00K$35.06525.87K
2024-06-07Crowley ElizabethSell7.50K$9.0267.62K
2024-06-07Young Diane C.Sell45.00K$35.261.59M
2024-06-05Jimenez Freddy A.Buy9.54K$10.3899.03K
2024-06-05Jimenez Freddy A.Sell9.54K$10.3899.03K
2024-06-03Heath-Chiozzi MargoBuy58.37K$10.38605.87K
2024-06-03Heath-Chiozzi MargoSell58.37K$10.38605.87K
2024-06-03Heath-Chiozzi MargoSell58.37K$33.651.96M
2024-06-03Heath-Chiozzi MargoBuy6.29K$9.0256.70K
2024-06-03Heath-Chiozzi MargoSell6.29K$9.0256.70K
2024-06-03Wright Richard M.Buy18.38K$22.48413.07K
2024-06-03Wright Richard M.Buy28.47K$28.00797.13K
2024-06-03Wright Richard M.Sell27.58K$33.53924.66K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 270, holders +36 vs prior quarter. Ownership 110.08%.

HolderSharesChangeChange %Value
WELLINGTON MANAGEMENT GROUP LLP9.54M983.20K+11.49%355.12M
BLACKROCK, INC.7.00M1.63M+30.40%260.56M
KYNAM CAPITAL MANAGEMENT, LP5.32M-517.66K-8.86%198.07M
PRICE T ROWE ASSOCIATES INC /MD/4.69M2.60M+124.57%174.34M
STATE STREET CORP3.90M1.10M+39.09%145.13M
FMR LLC3.72M-26.16K-0.70%138.53M
VANGUARD CAPITAL MANAGEMENT LLC3.46M503.94K+17.02%128.93M
DEEP TRACK CAPITAL, LP2.94M1.66M+128.91%109.37M
LOGOS GLOBAL MANAGEMENT LP2.10M1.65M+366.67%78.14M
GEODE CAPITAL MANAGEMENT, LLC2.02M334.15K+19.79%75.26M
EVERSEPT PARTNERS, LP1.79M-2.08K-0.12%66.45M
GOLDMAN SACHS GROUP INC1.62M626.93K+63.43%60.11M
COMMODORE CAPITAL LP1.35M-1.35M-49.94%50.23M
BELLEVUE GROUP AG1.20M00.00%44.65M
BAKER BROS. ADVISORS LP1.18M517.24K+77.74%44.00M
MILLENNIUM MANAGEMENT LLC1.17M-82.75K-6.60%43.56M
DIMENSIONAL FUND ADVISORS LP1.07M14.45K+1.36%39.96M
AMERICAN CENTURY COMPANIES INC1.04M186.09K+21.73%38.79M
EVENTIDE ASSET MANAGEMENT, LLC1.04M00.00%38.59M
NOVO HOLDINGS A/S1.02M-175.00K-14.58%38.14M
ELMIND CAPITAL, LP990.00K125.00K+14.45%36.84M
DRIEHAUS CAPITAL MANAGEMENT LLC989.44K989.44KNew36.82M
FISHER ASSET MANAGEMENT, LLC985.68K-27.97K-2.76%36.68M
PICTET ASSET MANAGEMENT HOLDING SA917.41K-6.29K-0.68%34.14M
FORESITE CAPITAL MANAGEMENT VI LLC879.71K563.80K+178.47%32.73M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Celldex Therapeutics (CLDX) Stock Insights

CLDX$29.66-0.49 -1.63%

$2.33B

Market Cap

-6.77

P/E

7.80

Forward P/E

—

Score

Price History